Official websites use the Texas HHS logo.
The Texas HHS logo means this is an official website of Texas Health and Human Services.
The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Adjunctive administration of multiple GLP-1 agonists is not recommended due to increased risk for adverse events with no additional therapeutic benefit. Exenatide regular-release should be discontinued prior to initiating exenatide extended-release therapy. Patient profiles containing prescriptions for multiple GLP-1 agonists will be reviewed.